BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 31.19
+1.39 (4.66%)
At close: Jul 10, 2026
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 13.57 billion as of July 10, 2026. Its market cap has decreased by -43.17% in one year.
Market Cap
13.57B
Enterprise Value
15.64B
Revenue
1.30B
Ranking
n/a
PE Ratio
262.24
Stock Price
31.19
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 13.57B, an increase of 8.17%. That is a compound annual growth rate of 1.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 13.57B | -34.55% |
| Dec 31, 2025 | 20.74B | 62.70% |
| Dec 31, 2024 | 12.75B | -13.79% |
| Dec 29, 2023 | 14.79B | 55.07% |
| Dec 30, 2022 | 9.54B | -36.65% |
| Dec 31, 2021 | 15.05B | -19.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HitGen | 14.37B |
| Mabwell (Shanghai) Bioscience | 13.66B |
| Anhui Anke Biotechnology (Group) | 13.50B |
| Jinyu Bio-technology | 13.31B |
| InventisBio | 12.96B |
| Staidson (Beijing) BioPharmaceuticals | 11.57B |
| Shanghai Medicilon | 11.44B |
| Inner Mongolia Furui Medical Science | 11.42B |